Construction of a family of Mycobacterium/Escherichia coli shuttle vectors derived from pAL5000 and pACYC184: their use for cloning an antibiotic-resistance gene from Mycobacterium fortuitum, Gene, vol.176, issue.1-2, pp.23-26, 1996. ,
DOI : 10.1016/0378-1119(96)00202-8
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis, Science, vol.263, issue.5144, pp.227-230, 1994. ,
DOI : 10.1126/science.8284673
BM 212 and its Derivatives as a New Class of Antimycobacterial Active Agents, Current Medicinal Chemistry, vol.9, issue.21, pp.1859-1869, 2002. ,
DOI : 10.2174/0929867023368953
Developing Pyrrole-Derived Antimycobacterial Agents: a Rational Lead Optimization Approach, ChemMedChem, vol.18, issue.4, pp.593-598, 2011. ,
DOI : 10.1002/cmdc.201000526
Multidrug-resistant and extensively drug-resistant tuberculosis: a review, Current Opinion in Infectious Diseases, vol.21, issue.6, pp.587-595, 2008. ,
DOI : 10.1097/QCO.0b013e328319bce6
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence, Nature, vol.25, issue.6685, pp.537-544, 1998. ,
DOI : 10.1038/31159
Bactericidal activities of the pyrrole derivative BM FIG 3 [ 14 C]BM212 accumulation by M. smegmatis wild-type and M. smegmatis MSMEG-GR12.5 cells. [ 14 C]BM212 was added to the cells at time zero, The results are the averages of data from three experiments, and error bars indicate standard deviations, 1998. ,
berculosis strains, Antimicrob. Agents Chemother, vol.42, pp.3035-3037 ,
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance, Infection and Immunity, vol.73, issue.6, pp.3492-3501, 2005. ,
DOI : 10.1128/IAI.73.6.3492-3501.2005
Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria, Molecular Microbiology, vol.7, issue.3, pp.407-417, 1993. ,
DOI : 10.1007/BF00266145
[25] Genetic systems for mycobacteria, Methods Enzymol, vol.204, pp.537-555, 1991. ,
DOI : 10.1016/0076-6879(91)04027-L
A Model Recognition Approach to the Prediction of All-Helical Membrane Protein Structure and Topology, Biochemistry, vol.33, issue.10, pp.3038-3049, 1994. ,
DOI : 10.1021/bi00176a037
Preclinical testing of new drugs for tuberculosis: current challenges, Trends in Microbiology, vol.16, issue.2, pp.48-54, 2008. ,
DOI : 10.1016/j.tim.2007.12.002
New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes, Current Opinion in Pulmonary Medicine, vol.16, pp.186-193, 2010. ,
DOI : 10.1097/MCP.0b013e328337580c
Inhibition of a Mycobacterium tuberculosis -Ketoacyl ACP Synthase by Isoniazid, Science, vol.280, issue.5369, pp.1607-1610, 1998. ,
DOI : 10.1126/science.280.5369.1607
Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nature Reviews Drug Discovery, vol.293, issue.1, pp.29-40, 2007. ,
DOI : 10.1038/nrd2201
Efflux pumps as antimicrobial resistance mechanisms, Annals of Medicine, vol.58, issue.1, pp.162-176, 2007. ,
DOI : 10.1093/jac/dkl441
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update, Tubercle and Lung Disease, vol.79, issue.1, pp.3-29, 1998. ,
DOI : 10.1054/tuld.1998.0002
: drug resistance and future perspectives, Future Microbiology, vol.4, issue.5, pp.597-614, 2009. ,
DOI : 10.2217/fmb.09.20
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis, Science, vol.279, issue.5347, pp.98-102, 1998. ,
DOI : 10.1126/science.279.5347.98
Molecular cloning: a laboratory manual, 2001. ,
Genetic studies on microbial cross resistance to toxic agents. 1. Cross resistance of Escherichia coli to 15 antibiotics, J. Bacteriol, vol.64, pp.489-499, 1952. ,
Discovery and characterization of a unique mycobacterial heme acquisition system, Proceedings of the National Academy of Sciences, vol.187, issue.4, pp.5051-5056, 2011. ,
DOI : 10.1128/JB.187.4.1238-1245.2005
Target Validation: Linking Target and Chemical Properties to Desired Product Profile, Current Topics in Medicinal Chemistry, vol.11, issue.10, pp.1275-1283, 2011. ,
DOI : 10.2174/156802611795429185